Intuitive Surgical (NASDAQ:ISRG) Given New $515.00 Price Target at BofA

Posted by Stanley Muller on Jun 12th, 2026

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) had its price objective decreased by equities research analysts at BofA from $520.00 to $515.00 in a note issued to investors on Friday,MarketScreener reports. BofA’s price target would suggest a potential upside of 26.72% from the stock’s previous close.

Other research analysts have also issued reports about the company. The Goldman Sachs Group set a $558.00 price objective on Intuitive Surgical in a research report on Wednesday, May 27th. JPMorgan Chase & Co. lowered their price objective on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Piper Sandler reaffirmed an “overweight” rating and issued a $580.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, June 2nd. Robert W. Baird increased their target price on Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Finally, BTIG Research reaffirmed a “buy” rating and issued a $574.00 target price on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. Nineteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $571.28.

Get Our Latest Stock Analysis on ISRG

Intuitive Surgical Trading Down 1.6%

NASDAQ:ISRG traded down $6.49 during trading hours on Friday, reaching $406.41. 382,900 shares of the company were exchanged, compared to its average volume of 2,093,754. The firm has a market cap of $143.93 billion, a PE ratio of 49.28, a price-to-earnings-growth ratio of 3.29 and a beta of 1.46. Intuitive Surgical has a twelve month low of $396.68 and a twelve month high of $603.88. The stock’s 50-day moving average is $443.95 and its 200-day moving average is $496.79.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.81 earnings per share. As a group, research analysts anticipate that Intuitive Surgical will post 8.57 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the transaction, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the sale, the director directly owned 239 shares of the company’s stock, valued at approximately $113,156.94. This trade represents a 67.66% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,144 shares of company stock worth $3,048,782 over the last three months. Insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Large investors have recently modified their holdings of the company. Holos Integrated Wealth LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at about $25,000. Newbridge Financial Services Group Inc. increased its holdings in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the period. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Caitlin John LLC purchased a new stake in shares of Intuitive Surgical during the third quarter worth approximately $30,000. Finally, Main Street Group LTD acquired a new stake in shares of Intuitive Surgical during the first quarter worth $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.